Added to YB: 2024-10-16
Pitch date: 2024-10-16
VRTX:US [bullish]
Vertex Pharmaceuticals Incorporated
-6.99%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
Market Cap
$108.3B
Pitch Price
$490.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.02
P/E
30.01
EV/Sales
8.37
Sector
Biotechnology
Category
N/A
Show full summary:
Vertex Pharmaceuticals Incorporated VRTX:US
A summary for this pitch has not been created yet.
Read full article (0 min)